Dawn Ipsen, PharmD – LDN Radio Show May 2023 (LDN; low dose naltrexone)

D Today we’re joined by pharmacist Dr Dawn Ipsen who’s the owner of two pharmacies in Washington State, Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist?  I knew early on as a high schooler that I wanted to have a doctorate degree in something […]

What to Avoid When Taking Low Dose Naltrexone? (News)

What to Avoid When Taking Low Dose Naltrexone? The iBulletin 13 July 2023 https://www.theibulletin.com/what-to-avoid-when-taking-low-dose-naltrexone-48416/ In smaller doses, LDN has been found to alleviate symptoms of various conditions including autoimmune diseases, chronic pain, and even some mental health disorders by modulating the immune system and promoting the production of endorphins, the body’s natural painkillers. This action […]

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia… (Abstract)

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis Biomedicines As revised 23 March 2023 https://www.mdpi.com/2227-9059/11/4/1087 Current pharmacologic treatments may provide limited analgesia in fibromyalgia and other chronic pain disorders. Low-dose naltrexone (LDN) has emerged as a potential analgesic option that […]

An Update on the Uses of Naltrexone in Clinical Practice (Abstract)

An Update on the Uses of Naltrexone in Clinical Practice Natural Medicine Journal 01 August 2022 https://www.naturalmedicinejournal.com/journal/an-update-on-the-uses-of-naltrexone-in-clinical-practice The principal purpose of this paper is to review various dosing options of naltrexone for use in clinical practice. Naltrexone can help treat a variety of conditions, including autoimmune diseases, neurodegenerative diseases, and acute or chronic pain, with […]

Repurposed drugs are cheap (News)

Repurposed drugs are cheap (News) Dr. John Campbell 09 February 2023 https://www.youtube.com/watch?v=Iw7Xz-wl5Lo Repurposed drugs are common in medicine, aspirin, morphine, viagra and prednisolone for example. After drugs have been on the market for about 15 years, their patent runs out and they can be mass produced as a very inexpensive ‘generic’ drug. Naltrexone is one […]

LDN therapy hope for the desired pregnancy? (in Polish) (News)

LDN therapy hope for the desired pregnancy? (in Polish) (News) Medexpress.pl 05 February 2023 https://www.medexpress.pl/terapia-ldn-nadzieja-na-upragniona-ciaze/86337 Recently, there have been a number of scientific papers showing that low-dose naltrexone may help treat some chronic conditions, such as Crohn’s disease, ulcerative colitis, irritable bowel syndrome, chronic fatigue syndrome, long COVID, anxiety, and in poor sleep quality and […]

How Long Does it Take Low Dose Naltrexone to Work? (News)

How Long Does it Take Low Dose Naltrexone to Work? The Enlightened Mindset 15 January 2023 https://www.lihpao.com/how-long-does-it-take-low-dose-naltrexone-to-work/ Low dose naltrexone (LDN) is becoming increasingly popular as an alternative treatment option for a wide variety of chronic conditions. It’s important to note that LDN does not work immediately and it can take several weeks or even […]

Low Dose Naltrexone, A Helpful Option to Battle Depression & Anxiety (News)

Low Dose Naltrexone, A Helpful Option to Battle Depression & Anxiety NewsDio 28 January 2021 https://newsdio.com/low-dose-naltrexone-a-helpful-option-to-battle-depression-anxiety/153280/ Prolonged periods of isolation, lockdown, and major traumatic events have caused a significant increase in the rates of anxiety and depression over the past year. Low dose naltrexone (LDN) boosts mood and increases energy. LDN is an effective, accessible, […]

Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic (Abstract)

Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic Int Immunopharmacol 09 November 2022 https://pubmed.ncbi.nlm.nih.gov/36379151/ Persons with multiple sclerosis (PwMS) have been considered at high risk for vaccination and/or acquisition of COVID-19 related to their reduced immune systems and daily regimen of immune suppressing therapy. Substantiated and unsubstantiated reports on these […]